Methotrexate Tablet
Product Images NDC 0555-0572

2 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0555-0572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure diagram of the active ingredient Methotrexate, showing its molecular framework with labeled atoms and bonds as part of a pharmaceutical product image.*
FDA Label Image

Image 2

Image 2
Methotrexate Tablets, USP 2.5 mg oral tablets label by Teva Pharmaceuticals USA, Inc. The label indicates 36 tablets per container with a caution that it is a cytotoxic agent. It provides storage instructions, a usual dosage note, and a warning to keep all medications out of reach of children. The NDC is 0555-0572-35, and a barcode is present along with serialization coding information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.